This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medtronic Drags Healthcare ETFs

NEW YORK ( TheStreet) -- Weak existing-home sales data and worse-than-expected results from Barnes & Noble (BKS) and Medtronic (MDT - Get Report) contributed to broad market weakness that is weighing on healthcare ETFs.

Healthcare stocks are trading lower after market leader Medtronic reported a decline in sales in the fiscal first-quarter and lowered its outlook for revenue and earnings for the year through next April. The iShares Dow Jones US Medical Devices (IHI), which has a 13.3% stake in Medtronic, is down 3.3%. Other top holdings in the fund including Thermo Fisher Scientific (TMO) and Stryker (SYK - Get Report) were also weaker. The PowerShares S&P SmallCap Health Care ETF (XLVS) and Health Care Select Sector SPDR (XLV) were declining by 0.9% and 1.8% respectively.

The 27% plunge in existing home sales data led to a selloff in the SPDR KBW Mortgage Finance ETF (KME) shedding 3.8%. The Homebuilder ETFs remarkably remained in the positive territory with the SPDR Homebuilders ETF (XHB) rising 0.4% and the Dow Jones Home Construction (ITB) rising 1.2%.

Prominent among the gainers is the CurrencyShares Japanese Yen Trust (FXY), which is gaining 1.2% as the Yen touched a 15-year high against the dollar.

The iShares Silver Trust (SLV) is another notable gainer in Tuesday trading, up 2.4%.

--Written by Shanthi Venkataraman in New York.

>To contact the writer of this article, click here: Shanthi Venkataraman.

>To follow the writer on Twitter, go to Shanthi Venkataraman.

>To submit a news tip, send an email to:
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ITB $22.99 0.00%
IHI $111.66 0.00%
MDT $74.46 0.00%
SLV $14.34 0.00%
SYK $96.91 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs